ALNYLAM PHARMACEUTICALS, INC. (ALNY) Total assets 2016–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) total assets at each fiscal year-end, per SEC filings.
$5.0BFY2025 · since FY2016: $1.3B → $5.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.0B | +17.1% |
| FY2024 | $4.2B | +10.7% |
| FY2023 | $3.8B | +8.0% |
| FY2022 | $3.5B | -2.7% |
| FY2021 | $3.6B | +6.9% |
| FY2020 | $3.4B | +42.2% |
| FY2019 | $2.4B | +52.1% |
| FY2018 | $1.6B | -21.1% |
| FY2017 | $2.0B | +58.0% |
| FY2016 | $1.3B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALNY financial trends
ALNY RevenueALNY Net incomeALNY Net marginALNY Gross profitALNY Gross marginALNY Operating incomeALNY Operating marginALNY Operating cash flowALNY Free cash flowALNY Capital expendituresALNY Return on equityALNY Stock buybacksALNY Dividends paidALNY Total liabilitiesALNY Shareholders’ equityALNY overview →